Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Solid Tumor Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
Biomed Phys Eng Express. 2024 Nov 21;11(1). doi: 10.1088/2057-1976/ad9153.
Colorectal cancer (CRC) remains a leading cause of cancer-related deaths worldwide, necessitating the development of novel therapeutic approaches. Carbon dots (CDs) have emerged as promising nanoparticles for biomedical applications due to their unique properties. Gallic acid (GA), an anticancer agent, is effective against various tumor types. This study explores the potential of gallic acid-derived carbon dots (GA-CDs) as an innovative anticancer agent against HCT-116 CRC cells, focusing on apoptosis signaling pathways. GA-CDs were synthesized using a one-pot hydrothermal method. Characterization was conducted using transmission electron microscopy (TEM), Fourier transform infrared (FT-IR) spectroscopy, and ultraviolet-visible (UV-vis) absorption spectroscopy. The cytotoxicity of GA and GA-CDs on HCT-116 cells was evaluated using the MTT assay at various concentrations over 24 and 48 h. Cellular uptake was assessed via fluorescence microscopy, and apoptosis was analyzed using acridine orange/propidium iodide (AO/PI) staining. Total RNA extraction followed by complementary DNA (cDNA) synthesis via reverse transcription-PCR was performed, and real time-PCR (Q-PCR) was conducted to examine the expression of apoptosis-related genes including3,, and2. Characterization confirmed the successful synthesis of spherical GA-CDs. GA-CDs exhibited dose- and time-dependent cytotoxicity, with IC50 values of 88.55 μg mlfor GA-CDs and 192.2 μg mlfor GA after 24 h. Fluorescence microscopy confirmed the efficient uptake of GA-CDs by HCT-116 cells. AO/PI staining showed a significant increase in apoptotic cell numbers after treatment with GA-CDs. Q-PCR analysis revealed overexpression of3 andgenes in GA-CD-treated cells, though no significant changes were observed in the expression of2 or the2 ratio. GA-CDs demonstrated potent anticancer properties by inducing apoptosis and reducing cell viability in HCT-116 cells. These findings suggest the potential of GA-CDs as a novel therapeutic agent for CRC treatment, warranting further investigation into their mechanism of action andefficacy.
结直肠癌(CRC)仍然是全球癌症相关死亡的主要原因,因此需要开发新的治疗方法。由于具有独特的性质,碳点(CDs)已成为生物医学应用中很有前途的纳米颗粒。没食子酸(GA)是一种有效的抗癌剂,对多种肿瘤类型均有疗效。本研究探讨了没食子酸衍生的碳点(GA-CDs)作为一种新型抗癌剂治疗 HCT-116 结直肠癌细胞的潜力,重点关注细胞凋亡信号通路。GA-CDs 是通过一锅水热法合成的。采用透射电子显微镜(TEM)、傅里叶变换红外(FT-IR)光谱和紫外-可见(UV-vis)吸收光谱对其进行了表征。采用 MTT 法在 24 和 48 h 不同浓度下评估 GA 和 GA-CDs 对 HCT-116 细胞的细胞毒性。通过荧光显微镜评估细胞摄取,并用吖啶橙/碘化丙啶(AO/PI)染色分析细胞凋亡。通过逆转录聚合酶链反应(RT-PCR)提取总 RNA 并合成 cDNA,然后进行实时 PCR(Q-PCR)以检测凋亡相关基因 3、、和 2 的表达。表征证实成功合成了球形 GA-CDs。GA-CDs 表现出剂量和时间依赖性的细胞毒性,24 h 时 GA-CDs 的 IC50 值为 88.55 μg ml,GA 的 IC50 值为 192.2 μg ml。荧光显微镜证实 GA-CDs 被 HCT-116 细胞有效摄取。AO/PI 染色显示 GA-CDs 处理后凋亡细胞数量显著增加。Q-PCR 分析显示 GA-CD 处理细胞中 3 和基因过表达,而 2 或 2 比值的表达无明显变化。GA-CDs 通过诱导 HCT-116 细胞凋亡和降低细胞活力显示出强大的抗癌特性。这些发现表明 GA-CDs 作为 CRC 治疗的新型治疗剂具有潜力,值得进一步研究其作用机制和疗效。